Sixty Degree Capital

Sixty Degree Capital

Exits 3

Investments 16

Investments

Series B - Antios Therapeutics

Antios Therapeutics75M USD

Series B - CinCor Pharma

CinCor Pharma143M USD

Series B - T-knife

T-knife110M USD

Series D - TransThera Biosciences

TransThera Biosciences100M USD

Series D - Turnstone Biologics

Turnstone Biologics80M USD

Series C - Arcellx

Arcellx115M USD

Series B - Antios Therapeutics

Antios Therapeutics96M USD

Series C - Monte Rosa Therapeutics

Monte Rosa Therapeutics95M USD

Series D - GrubMarket

GrubMarket90M USD

Series B - Monte Rosa Therapeutics

Monte Rosa Therapeutics96M USD

Verticals

AI

Cloud Infrastructure

Digital Health

E-commerce

Enterprise Applications

FinTech

Insurance

Marketplaces

SaaS

Sales & CRM

Investors

Access all investors here

Access more information on Sixty Degree Capital
Join now